Sign in
4

Changes in Ownership

Xilio Therapeutics, Inc. Filed Acc 0001104659-21-129570

Options or other derivatives

  • President of R&D and CMO acquired 157,058 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Huber Martin H. Jr. · President of R&D and CMO

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-10-21 Grant or award : show line 1 in the form Stock Option (right to buy) +157,058 157,058 D
Loading xslF345X03/tm2130646-21_4seq1.xml…